Aspirin at stroke prevention. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy1

Atrial Appendage

Diseases19

Stroke Brain Ischemia Atrial Fibrillation Cerebrovascular Disorders Ischemic Attack, Transient Hemorrhage Cerebral Hemorrhage Recurrence Cerebral Infarction Thromboembolism Carotid Stenosis Carotid Artery Diseases Foramen Ovale, Patent Intracranial Embolism Hypertension Anemia, Sickle Cell Embolism Heart Diseases Acute Disease

Chemicals and Drugs22

Aspirin Platelet Aggregation Inhibitors Anti-Inflammatory Agents, Non-Steroidal Warfarin Anticoagulants beta-Alanine Pyridones Fibrinolytic Agents Benzimidazoles Ticlopidine Thiophenes Dipyridamole Benzylamines Azetidines Pyrazoles Antisickling Agents Vitamin K Hydroxymethylglutaryl-CoA Reductase Inhibitors Antihypertensive Agents Thromboxane B2 Morpholines Cyclooxygenase Inhibitors

Analytical, Diagnostic and Therapeutic Techniques and Equipment26

Risk Factors Randomized Controlled Trials as Topic Treatment Outcome Endarterectomy, Carotid Prospective Studies Follow-Up Studies Incidence Risk Assessment International Normalized Ratio Cohort Studies Clinical Trials as Topic Drug Therapy, Combination Quality-Adjusted Life Years Administration, Oral Double-Blind Method Retrospective Studies Multicenter Studies as Topic Risk Septal Occluder Device Ultrasonography, Doppler, Transcranial Patient Selection Prevalence Registries Odds Ratio Markov Chains Multivariate Analysis

Phenomena and Processes6

Time Factors Risk Odds Ratio Markov Chains Platelet Aggregation Dose-Response Relationship, Drug

Disciplines and Occupations1

Evidence-Based Medicine

Anthropology, Education, Sociology and Social Phenomena1

Centers for Disease Control and Prevention (U.S.)

Information Science4

Incidence Quality-Adjusted Life Years Prevalence Registries

Health Care29

Secondary Prevention Risk Factors Primary Prevention Randomized Controlled Trials as Topic Treatment Outcome Prospective Studies Follow-Up Studies Incidence Risk Assessment Cohort Studies Clinical Trials as Topic Cost-Benefit Analysis Quality-Adjusted Life Years Comorbidity Double-Blind Method Age Factors Practice Guidelines as Topic Retrospective Studies Multicenter Studies as Topic Risk Sex Factors Patient Selection Prevalence Registries Odds Ratio Markov Chains Centers for Disease Control and Prevention (U.S.)Guideline Adherence Multivariate Analysis

Geographicals2

Austria United States

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Health Care Geographicals

Aspirin Stroke Platelet Aggregation Inhibitors Brain Ischemia Anti-Inflammatory Agents, Non-Steroidal Warfarin Anticoagulants Atrial Fibrillation Secondary Prevention Cerebrovascular Disorders beta-Alanine Risk Factors Ischemic Attack, Transient Primary Prevention Pyridones Fibrinolytic Agents Randomized Controlled Trials as Topic Atrial Appendage Treatment Outcome Benzimidazoles Endarterectomy, Carotid Hemorrhage Cerebral Hemorrhage Recurrence Cerebral Infarction Thromboembolism Austria Ticlopidine Prospective Studies Follow-Up Studies Thiophenes Incidence Time Factors Dipyridamole Carotid Stenosis Risk Assessment International Normalized Ratio Benzylamines United States Azetidines Cohort Studies Clinical Trials as Topic Cost-Benefit Analysis Drug Therapy, Combination Carotid Artery Diseases Foramen Ovale, Patent Intracranial Embolism Hypertension Quality-Adjusted Life Years Anemia, Sickle Cell Comorbidity Pyrazoles Administration, Oral Antisickling Agents Double-Blind Method Embolism Vitamin K Age Factors Practice Guidelines as Topic Retrospective Studies Multicenter Studies as Topic Risk Hydroxymethylglutaryl-CoA Reductase Inhibitors Sex Factors Antihypertensive Agents Septal Occluder Device Ultrasonography, Doppler, Transcranial Patient Selection Prevalence Registries Odds Ratio Heart Diseases Thromboxane B2 Markov Chains Centers for Disease Control and Prevention (U.S.)Guideline Adherence Multivariate Analysis Morpholines Cyclooxygenase Inhibitors Evidence-Based Medicine Acute Disease Platelet Aggregation Dose-Response Relationship, Drug

No FAQ available that match "aspirin at stroke prevention"